Latest Breaking News On - Erica mayer - Page 1 : vimarsana.com

Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer

Trastuzumab deruxtecan extended its superiority versus chemotherapy into HER2-ultralow

One in Five BRCA-Positive Breast Cancer Patients Able to Conceive

Disease-free survival comparable between patients who did and did not become pregnant

Debunked claims linking bras to breast cancer resurface online

A decades-old myth that wearing bras leads to breast cancer is recirculating on social media. The claim is false; scientists say studies have found no causal link, and the misplaced belief probably stems from research showing slimmer women had lower rates of the disease.

Boston Women Unite to Address Inequities in Cancer Care at Dana-Farber

Real-World Survival Benefit With CDK4/6 Inhibitors in MBC

Registry data confirm an overall survival benefit when a CDK4/6 inhibitor is added to endocrine therapy in HR-positive metastatic breast cancer.

Continuing CDK4/6 Inhibitor Beyond Progression No Help in Metastatic Breast Cancer

Prior therapy, baseline mutations confound results; 'intriguing' benefit with PD-L1 inhibitor

Dana-Farber researchers to present findings at San Antonio Breast Cancer Symposium 3 December

The Latest Treatments for Metastatic Breast Cancer Are Giving People a Fighting Chance

Newer treatments for metastatic breast cancer are helping patients live longer and offering new hope.

Immune-Based Therapy Shows Promise Against Advanced Breast Cancers

WEDNESDAY, Feb. 9, 2022 (HealthDay News) -- An experimental therapy that harnesses the body's tumor-fighting immune cells may be effective for some women with advanced breast cancer, early research suggests.

Immune-Based Therapy Shows Promise Against Advanced Breast Cancers

WEDNESDAY, Feb. 9, 2022 (HealthDay News) -- An experimental therapy that harnesses the body's tumor-fighting immune cells may be effective for some women with advanced breast cancer, early research suggests.